NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · VIBEF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Vibe Growth Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.82% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Vibe Growth Corporation’s next earnings report is currently expected on Nov 26, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vibe Growth Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vibe Growth Corporation operates across various segments of the cannabis industry, catering to both recreational and medical consumers. The company is involved in the full spectrum of activities, including cultivating, producing, manufacturing, and distributing cannabis products. Its operational footprint includes five retail dispensaries, two cultivation facilities, and a dedicated distribution center. Products are also accessible to customers through its online platform, operating under the 'Vibe By California' brand, which offers e-commerce and home delivery services. Specializing in indoor cultivation, Vibe Growth Corporation handles commercial distribution, transportation, and manufacturing of its marijuana products. Established in 2020, the company was initially known as Vibe Bioscience Ltd. before officially rebranding to Vibe Growth Corporation in October of the same year. It maintains its headquarters in Sacramento, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$0.40 |
| $3.07M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$0.02-$0.00 (-6.84%)
Pure Harvest Corporate Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.13% below the high.
A$0.01A$0.00 (0.0%)
Elixinol Wellness Limited’s quoted price sits in the lower half of its reported 52-week range, 72.73% below the high.
$0.00$0.00 (0.0%)
Nutra Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.00$0.00 (0.0%)
NeutriSci International Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
Cannabis Suisse Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00+$0.00 (+9.38%)
MC Endeavors, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.98% below the high.
$0.00$0.00 (0.0%)
Indocan Resources Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
